DK1185873T3 - Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet - Google Patents
Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitetInfo
- Publication number
- DK1185873T3 DK1185873T3 DK00936829T DK00936829T DK1185873T3 DK 1185873 T3 DK1185873 T3 DK 1185873T3 DK 00936829 T DK00936829 T DK 00936829T DK 00936829 T DK00936829 T DK 00936829T DK 1185873 T3 DK1185873 T3 DK 1185873T3
- Authority
- DK
- Denmark
- Prior art keywords
- protease activity
- reporter molecules
- entity
- analyzing high
- cell
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99201659A EP1055929A1 (fr) | 1999-05-26 | 1999-05-26 | Moyens et procédé pour la découverte des médicaments et la caractérisation des cellules |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1185873T3 true DK1185873T3 (da) | 2006-01-30 |
Family
ID=8240238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00936829T DK1185873T3 (da) | 1999-05-26 | 2000-05-26 | Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet |
Country Status (9)
Country | Link |
---|---|
US (1) | US7129036B1 (fr) |
EP (3) | EP1055929A1 (fr) |
AT (2) | ATE361374T1 (fr) |
AU (2) | AU778272B2 (fr) |
CA (2) | CA2374038A1 (fr) |
DE (2) | DE60022879T2 (fr) |
DK (1) | DK1185873T3 (fr) |
ES (1) | ES2249273T3 (fr) |
WO (2) | WO2000073802A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756207B1 (en) | 1997-02-27 | 2004-06-29 | Cellomics, Inc. | System for cell-based screening |
EP2135943A1 (fr) * | 2001-07-30 | 2009-12-23 | Meso Scale Technologies, LLC. | Électrode de réseau dotée de couches de lipide/protéine immobilisées, son procédé de fabrication et procédés d'utilisation associés pour les mesures de test de luminescence |
CN101684161A (zh) | 2001-08-10 | 2010-03-31 | 阿赫姆生物系统公司 | 蛋白酶检测系统 |
WO2009015071A1 (fr) * | 2007-07-23 | 2009-01-29 | Dharmacon, Inc. | Criblage de bains inhibiteurs d'agrégat de micro-arn |
WO2009100760A1 (fr) * | 2008-02-13 | 2009-08-20 | Novartis Ag | Essai de criblage cellulaire pour des modulateurs de la voie de la mévalonate |
US20150026834A1 (en) | 2012-03-07 | 2015-01-22 | The Johns Kopkins University | Anastasis biosensor |
EP3542162B1 (fr) * | 2016-11-16 | 2021-09-01 | The Johns Hopkins University | Biocapteur d'anastase |
WO2019099769A1 (fr) | 2017-11-16 | 2019-05-23 | The Johns Hopkins University | Biocapteur d'anastase "caspase tracker" |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9226065D0 (en) * | 1992-12-14 | 1993-02-10 | Ici Plc | Peptides |
DK0815257T3 (da) * | 1995-01-31 | 2002-04-22 | Bioimage As | Fremgangsmåde til karakterisering af biologisk aktive stoffer |
JP2000504220A (ja) | 1996-01-23 | 2000-04-11 | ライガル ファーマシューティカルズ インコーポレイテッド | トランス支配性細胞内作用因子ペプチドおよびrna分子のスクリーニング方法 |
DK0986753T4 (da) * | 1997-04-07 | 2005-12-19 | Bioimage As | Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons |
CN1281346A (zh) * | 1997-10-10 | 2001-01-24 | 西托维亚公司 | 新型荧光报道分子及其应用,包括对胱天肽酶的测定 |
-
1999
- 1999-05-26 EP EP99201659A patent/EP1055929A1/fr not_active Withdrawn
-
2000
- 2000-05-26 WO PCT/EP2000/004923 patent/WO2000073802A1/fr active IP Right Grant
- 2000-05-26 ES ES00936829T patent/ES2249273T3/es not_active Expired - Lifetime
- 2000-05-26 AT AT00941999T patent/ATE361374T1/de not_active IP Right Cessation
- 2000-05-26 US US09/979,170 patent/US7129036B1/en not_active Expired - Fee Related
- 2000-05-26 AU AU56767/00A patent/AU778272B2/en not_active Ceased
- 2000-05-26 AU AU52177/00A patent/AU777118B2/en not_active Ceased
- 2000-05-26 AT AT00936829T patent/ATE305612T1/de not_active IP Right Cessation
- 2000-05-26 WO PCT/EP2000/004919 patent/WO2000073497A1/fr active IP Right Grant
- 2000-05-26 CA CA002374038A patent/CA2374038A1/fr not_active Abandoned
- 2000-05-26 CA CA002374047A patent/CA2374047A1/fr not_active Abandoned
- 2000-05-26 DE DE60022879T patent/DE60022879T2/de not_active Expired - Fee Related
- 2000-05-26 EP EP00936829A patent/EP1185873B8/fr not_active Expired - Lifetime
- 2000-05-26 EP EP00941999A patent/EP1185689B1/fr not_active Expired - Lifetime
- 2000-05-26 DE DE60034672T patent/DE60034672D1/de not_active Expired - Lifetime
- 2000-05-26 DK DK00936829T patent/DK1185873T3/da active
Also Published As
Publication number | Publication date |
---|---|
ES2249273T3 (es) | 2006-04-01 |
EP1185689B1 (fr) | 2007-05-02 |
AU5217700A (en) | 2000-12-18 |
DE60022879T2 (de) | 2006-07-20 |
WO2000073497A1 (fr) | 2000-12-07 |
EP1185873A1 (fr) | 2002-03-13 |
ATE305612T1 (de) | 2005-10-15 |
ATE361374T1 (de) | 2007-05-15 |
EP1055929A1 (fr) | 2000-11-29 |
AU777118B2 (en) | 2004-09-30 |
DE60034672D1 (de) | 2007-06-14 |
EP1185689A1 (fr) | 2002-03-13 |
EP1185873B8 (fr) | 2005-11-23 |
CA2374038A1 (fr) | 2000-12-07 |
DE60022879D1 (de) | 2006-02-09 |
US7129036B1 (en) | 2006-10-31 |
AU5676700A (en) | 2000-12-18 |
AU778272B2 (en) | 2004-11-25 |
EP1185873B1 (fr) | 2005-09-28 |
CA2374047A1 (fr) | 2000-12-07 |
WO2000073802A1 (fr) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK505489D0 (da) | Apparat og fremgangsmaade til indikering af tilboejelighed til dannelse af nyresten og til dehydrering, isaer hos mennesker | |
DE60136292D1 (de) | Multiarraysystem zur integration von bioarrays | |
DK1342093T3 (da) | Elektrokemiske biosensorer | |
DE59004587D1 (de) | Messzelle für den elektrochemischen Gasnachweis. | |
DE69941429D1 (de) | 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a | |
DK1011425T3 (da) | Indretning og apparat til bestemmelse af analytniveauer | |
WO2003066876A3 (fr) | Appareil et procedes permettant de discriminer un agent a l'aide de matiere biologique | |
ATE490466T1 (de) | Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen | |
ES2316597T8 (es) | Instrumentos analíticos, biosensores y métodos | |
AU4007401A (en) | Function homology screening | |
BR0207775A (pt) | Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização | |
DE69839250D1 (de) | Verbesserte elektrochemische biosensor-teststreifen | |
BRPI0002963B1 (pt) | processo e dispositivo medidor eletroquìmico para medir uma concentração de analito em uma amostra. | |
DK1088084T3 (da) | Erythropoietin analog-humant serumalbumin fusionsprotein | |
AU3227400A (en) | Flow cell, analyte measurement apparatus and methods related thereto | |
DE60142048D1 (de) | Universelles sammelmedium | |
GB2430740A (en) | System and method for tracking and quatitating chemical entites | |
CY1107380T1 (el) | Πρωτεϊνες συντηξης που περιλαμβανουν δυο διαλυτα gp130 μορια | |
DK1185873T3 (da) | Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet | |
ATE239274T1 (de) | Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben | |
AU2002237940A1 (en) | System and method for in vitro analysis of therapeutic agents | |
WO2000023615A3 (fr) | Procede ameliore destine a une extraction quantitative d'information se rapportant a une influence sur une reponse cellulaire | |
DE60139056D1 (de) | Blutzellen-Detektor, Blutanalysegerät und Blutanalyseverfahren unter Verwendung des Detektors | |
FI981428A0 (fi) | Referenssiaine käytettäväksi levosimendaanierien analyysissä | |
ATE421693T1 (de) | Proteine in der diabetes-proteomanalyse |